Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eicosanoids in preeclampsia.

Scott W Walsh1

  • 1Department of Obstetrics and Gynecology, Virginia Commonwealth University, 1101 E Marshall St., PO Box 980034, Richmond, VA 23298-0034, USA. swwalsh@hsc.vcu.edu

Prostaglandins, Leukotrienes, and Essential Fatty Acids
|December 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy.

Journal of lipid research·2023
Same author

Aspirin Inhibits the Inflammatory Response of Protease-Activated Receptor 1 in Pregnancy Neutrophils: Implications for Treating Women with Preeclampsia.

International journal of molecular sciences·2022
Same author

Gene Expression of Pregnancy Neutrophils Differs for Protease versus Lipopolysaccharide Stimulation.

International journal of molecular sciences·2022
Same author

Pregnancy-specific expression of protease-activated receptor 1: a therapeutic target for prevention and treatment of preeclampsia?

American journal of obstetrics and gynecology·2022
Same author

Patterns of Maternal Neutrophil Gene Expression at 30 Weeks of Gestation, but Not DNA Methylation, Distinguish Mild from Severe Preeclampsia.

International journal of molecular sciences·2021
Same author

The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta.

International journal of molecular sciences·2021
Same journal

Cardiovascular safety profile of prostaglandin E and prostacyclin analogues: Clinical reports and ex vivo studies on human coronary arteries.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Specialized pro-resolving mediator (SPM)-enriched supplementation modulates inflammatory biomarkers in patients with symptomatic knee osteoarthritis: Blood plasma analysis from the GAUDI study.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Serum fatty acid distributions and prevalence of low omega-3 status in early pregnancy: A cross-sectional analysis of 26,389 samples from an omega-3 test-and-treat program.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Association of fish intake with systemic immune-inflammation index: Potential mediating role of n-3 polyunsaturated fatty acids.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

A novel algae oil-based emulsion enhances chemotherapy outcome in human cancer models.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Human milk omega-3 PUFA and infant neurodevelopment: Evidence and insights from indian mothers.

Prostaglandins, leukotrienes, and essential fatty acids·2026
See all related articles

Preeclampsia involves an imbalance favoring thromboxane over prostacyclin, potentially caused by oxidative stress. Low-dose aspirin may prevent preeclampsia, but compliance is key for effectiveness.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiovascular Research
  • Biochemistry

Background:

  • Preeclampsia is characterized by an imbalance between thromboxane and prostacyclin, favoring thromboxane.
  • This imbalance contributes to hypertension, platelet aggregation, and reduced uteroplacental blood flow in preeclampsia.
  • The imbalance is linked to oxidative stress, increased lipid peroxidation, and decreased antioxidant protection.

Purpose of the Study:

  • To investigate the role of thromboxane/prostacyclin imbalance in preeclampsia pathogenesis.
  • To explore the potential of low-dose aspirin therapy for preeclampsia prevention.
  • To assess the impact of compliance on aspirin's effectiveness in preventing preeclampsia.

Main Methods:

  • Longitudinal measurements of urinary thromboxane and prostacyclin metabolites.

Related Experiment Videos

  • Analysis of prostacyclin production by endothelial cells.
  • Review of clinical trial data on low-dose aspirin therapy for preeclampsia prevention, including compliance rates.

    • Main Results:

    • The thromboxane/prostacyclin imbalance precedes clinical symptoms of preeclampsia.
    • Oxidative stress appears to drive this imbalance by affecting cyclooxygenase and prostacyclin synthase.
    • Low-dose aspirin showed potential for prevention, but compliance issues in large trials limited observed efficacy.

    Conclusions:

    • The thromboxane/prostacyclin imbalance, driven by oxidative stress, is a key feature of preeclampsia.
    • Low-dose aspirin therapy warrants reconsideration for preeclampsia prevention, emphasizing patient compliance and potentially higher doses (100-150 mg/day) combined with antioxidants.